Milk For C/S at Ayzal Lab

Book at Ayzal Lab · Lahore

Book this test

Ayzal Lab logo

Ayzal Lab

30% off
Rs. 1,645Rs. 2,350

Milk For C/S at Ayzal Lab

Milk for Culture and Sensitivity (C/S) is a specialized microbiological laboratory investigation performed to identify the presence of pathogenic microorganisms, primarily bacteria, in human breast milk and to determine their susceptibility to specific antimicrobial agents. This diagnostic test is of paramount clinical importance in the management of lactational mastitis, recurrent breast infections, and non-resolving inflammatory conditions of the breast. By isolating the causative pathogen and performing susceptibility testing, clinical microbiologists provide essential data that guides prescribing physicians in selecting the most effective targeted antibiotic therapy, thereby avoiding empirical treatment failures and minimizing the risk of antimicrobial resistance.

At Ayzal Lab, located in Gujranwala, Pakistan, this diagnostic procedure is conducted using state-of-the-art microbiological techniques and sterile processing protocols. The examination evaluates the bacterial flora present in the milk sample, distinguishing between normal skin commensals and true pathogens such as Staphylococcus aureus, Streptococcus species, and various Gram-negative bacilli. The clinical value of this test lies in its ability to prevent complications such as breast abscess formation, systemic maternal infection, and unnecessary cessation of breastfeeding. Through precise identification and sensitivity profiling, Ayzal Lab supports maternal-fetal health and clinical decision-making with high-quality, reliable diagnostic services.

Clinical Procedure: What to Expect

Patient Preparation

Proper preparation is critical to prevent contamination of the breast milk sample with normal skin flora, which can lead to false-positive results and inappropriate antibiotic prescriptions. Patients should adhere to the following preparation guidelines:

  • Hygiene: Wash hands thoroughly with soap and warm water before expressing milk. Clean the breast and nipple area with sterile water or mild soap, then dry with a clean, lint-free towel. Avoid using alcohol wipes unless specifically instructed, as they may dry the skin or interfere with the sample.
  • Timing: It is highly recommended to collect the sample before initiating any antibiotic therapy. If you are already taking antibiotics, inform the laboratory staff and your physician, as this can suppress bacterial growth in the culture.
  • Equipment: Use only the sterile specimen container provided by Ayzal Lab. Do not touch the inside of the container or the lid to maintain sterility.
  • Expression Method: Manual expression is generally preferred over using a breast pump, as breast pumps can be difficult to sterilize completely and may introduce environmental contaminants. If a pump must be used, ensure all parts have been thoroughly sterilized according to medical standards.

During the Procedure

The collection of milk for C/S is a non-invasive process that can be performed at home or within the clinical collection areas of Ayzal Lab. The procedure involves the following steps:

  • Discarding Initial Drops: Express and discard the first few drops of milk (approximately 1-2 mL). This initial milk often contains colonizing bacteria from the nipple surface and lactiferous ducts, which do not represent the true internal microbiological environment.
  • Sample Collection: Express the subsequent milk directly into the sterile container. A sample volume of 5 to 10 mL is typically sufficient for comprehensive microbiological analysis.
  • Securing the Container: Immediately seal the container tightly with the sterile lid to prevent external contamination or leakage.
  • Labeling and Transport: Clearly label the container with your full name, registration number, date, and time of collection. The sample must be delivered to Ayzal Lab immediately. If a delay is unavoidable, store the sample in a refrigerator at 2-8°C and transport it in an insulated cool box with ice packs within 24 hours. Do not freeze the sample.
  • Laboratory Processing: Upon receipt, the laboratory technologist inoculates the milk sample onto specific culture media (such as Blood Agar and MacConkey Agar). The plates are incubated under controlled aerobic conditions at 37°C for 24 to 48 hours to observe bacterial colony growth. If growth is detected, further biochemical tests and automated susceptibility panels are performed.

When is a Milk For C/S Performed?

Lactational Mastitis

Lactational mastitis is an inflammatory condition of the breast tissue that is frequently associated with bacterial infection, particularly in breastfeeding mothers. Physicians request a Milk C/S when mastitis does not respond to initial empirical antibiotic therapy within 48 hours, or if the infection is severe, recurrent, or hospital-acquired. The test helps identify the specific pathogen, such as Methicillin-Resistant Staphylococcus aureus (MRSA), ensuring that the patient receives targeted, effective treatment.

Recurrent Breast Infections

When a patient experiences multiple episodes of breast infection or mastitis, it indicates either incomplete eradication of the primary pathogen or reinfection. A Milk C/S is crucial in these cases to determine if the recurrent infection is caused by the same organism with developed resistance or by a different pathogen altogether. This guides the clinician in formulating a long-term management plan, which may include prolonged targeted antibiotic courses or addressing underlying anatomical or latching issues.

Suspected Breast Abscess

A breast abscess is a localized collection of pus within the breast tissue, often arising as a complication of untreated or inadequately treated mastitis. If an abscess is suspected or has been drained, culturing the breast milk alongside the abscess fluid is essential. This helps confirm whether the parenchymal milk ducts are involved in the infectious process and ensures that systemic antibiotic therapy aligns perfectly with the sensitivity profile of the causative organism.

Neonatal Infection Risk

In cases where a breastfeeding infant shows signs of systemic infection, sepsis, or localized bacterial infections, and the mother is suspected of having subclinical mastitis, a Milk C/S is performed. Pathogens can be transmitted through breast milk, and identifying matching bacterial strains in both mother and infant is vital for coordinating treatment. This ensures both patients are treated simultaneously, preventing reinfection cycles.

Non-Lactational Mastitis

Although less common, mastitis can occur in non-lactating individuals, often associated with duct ectasia, smoking, or underlying medical conditions like diabetes. A Milk C/S (or nipple discharge culture) is performed to rule out atypical pathogens, including anaerobic bacteria or mycobacteria, which require highly specific antimicrobial regimens different from standard aerobic mastitis treatments.

What Does a Milk For C/S Detect?

A Milk for Culture and Sensitivity test is designed to detect, isolate, and profile various microbiological entities and clinical parameters. The test evaluates:

  • Presence of pathogenic aerobic bacteria
  • Growth of Gram-positive cocci (e.g., Staphylococcus aureus)
  • Identification of Methicillin-Resistant Staphylococcus aureus (MRSA)
  • Presence of Streptococcus agalactiae (Group B Streptococcus)
  • Growth of Gram-negative bacilli (e.g., Escherichia coli, Klebsiella pneumoniae)
  • Presence of Pseudomonas aeruginosa
  • Growth of Enterococcus species
  • Presence of fungal pathogens or yeast (e.g., Candida albicans)
  • Distinction between pathogenic growth and normal skin flora contamination
  • Semi-quantitative bacterial colony count (colony-forming units per milliliter, CFU/mL)
  • Susceptibility to Beta-lactam antibiotics (e.g., Penicillins, Cephalosporins)
  • Sensitivity to Macrolides (e.g., Erythromycin, Azithromycin)
  • Sensitivity to Lincosamides (e.g., Clindamycin)
  • Susceptibility to Glycopeptides (e.g., Vancomycin)
  • Sensitivity to Fluoroquinolones (e.g., Ciprofloxacin)
  • Presence of multi-drug resistant (MDR) bacterial strains
  • Inducible clindamycin resistance (D-zone test positive/negative)
  • Presence of inflammatory cells (polymorphonuclear leukocytes) in the sample
  • Atypical pathogens requiring specialized incubation conditions
  • Contamination from improper sample collection techniques

Turnaround Time and Report Access at Ayzal Lab

At Ayzal Lab, we understand the clinical urgency associated with breast infections, especially for nursing mothers and their infants. The initial culture observation requires 24 hours of incubation. If no bacterial growth is detected, a preliminary report may be generated. However, if pathogenic bacteria are isolated, an additional 24 hours is required to perform biochemical identification and antimicrobial susceptibility testing. Therefore, the final comprehensive Milk C/S report is typically available within 48 to 72 hours from the time of sample receipt.

Ayzal Lab provides convenient digital report access to ensure patients and healthcare providers can retrieve results promptly. Once the report is verified by our consultant microbiologist, an automated SMS notification is sent to the patient’s registered mobile number. Reports can be downloaded directly from the official Ayzal Lab online portal using the unique patient ID and password provided on the booking receipt. Physical copies of the report can also be collected from our main facility in Gujranwala or any designated collection center.

Milk For C/S Findings Overview

Structure / Parameter Evaluated Normal Findings Possible Abnormal Findings
Bacterial Growth No growth or growth of normal skin commensals only (e.g., Coagulase-negative Staphylococci < 1,000 CFU/mL) Significant growth of pathogens (e.g., Staphylococcus aureus > 1,000 CFU/mL)
Gram-Positive Pathogens Absent Presence of Staphylococcus aureus, Streptococcus pyogenes, or Enterococcus faecalis
Gram-Negative Pathogens Absent Presence of Escherichia coli, Klebsiella pneumoniae, or Pseudomonas aeruginosa
Fungal / Yeast Growth Absent Presence of Candida albicans or other Candida species
Colony Count (CFU/mL) < 1,000 CFU/mL of mixed skin flora ≥ 1,000 CFU/mL of a single pathogenic organism
Antimicrobial Susceptibility Not applicable (no pathogen isolated) Identification of sensitive, intermediate, or resistant profiles to specific antibiotics
Leukocyte Count (Microscopic) Few or absent polymorphonuclear leukocytes Abundant polymorphonuclear leukocytes (indicating active inflammatory/infectious process)

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Ayzal Lab for Milk For C/S?

  • Experienced Healthcare Professionals: Our laboratory is staffed by highly qualified microbiologists and medical technologists dedicated to diagnostic accuracy.
  • Patient-Focused Care: We prioritize patient comfort, privacy, and clear communication throughout the sample collection and reporting process.
  • Quality Diagnostic Services: Ayzal Lab adheres to strict internal and external quality control protocols to ensure reliable, reproducible test results.
  • Professional Reporting: Our reports are structured clearly, providing detailed susceptibility profiles that are easy for clinicians to interpret.
  • Modern Diagnostic Approach: We utilize advanced incubation and identification systems to detect pathogens rapidly and accurately.
  • Comfortable Environment: Our collection centers in Gujranwala are designed to provide a clean, hygienic, and welcoming experience for patients.
  • Convenient Location: Easily accessible facilities across Gujranwala make sample drop-off quick and hassle-free.
  • Commitment to Accurate Diagnosis: We understand the impact of our results on maternal and neonatal health, driving our commitment to clinical excellence.

Frequently Asked Questions